Nuvectis Pharma Inc. (NVCT)
NASDAQ: NVCT
· Real-Time Price · USD
6.47
0.04 (0.62%)
At close: Aug 15, 2025, 3:59 PM
6.43
-0.62%
After-hours: Aug 15, 2025, 04:10 PM EDT
Nuvectis Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 26.8M | 26.8M | 26.8M | -4.1M | -4.1M | -4.1M | n/a | 4.25M | 4.25M | 4.25M | 149K | 4K | 4K | 4K | 4K | n/a | n/a | n/a |
Cost of Revenue | 17.76M | 22.4M | 26.8M | 24.36M | 26.16M | 27.29M | 22.9M | 11.93M | 5.77M | 3.57M | 6.52M | 6.52M | 6.52M | 2.94M | n/a | n/a | n/a | n/a |
Gross Profit | 9.04M | 4.4M | n/a | -28.47M | -30.27M | -31.39M | -22.9M | -7.68M | -1.52M | 677K | -6.37M | -6.51M | -6.51M | -2.94M | 4K | n/a | n/a | n/a |
Operating Income | -22.97M | -21.02M | -19.85M | -20.26M | -22.06M | -23.19M | -22.9M | -22.81M | -22.59M | -20.39M | -19.23M | -14.72M | -13.45M | -15.81M | -12.89M | -10.63M | -5.96M | -23K |
Interest Income | 904K | 858K | 847K | 890K | 961K | 810K | 637K | 475K | 259K | 199K | 149K | 67K | 6K | 2K | n/a | n/a | n/a | n/a |
Pretax Income | -22.07M | -20.16M | -19M | -19.37M | -21.1M | -22.38M | -22.26M | -22.33M | -22.33M | -20.19M | -19.09M | -14.65M | -13.44M | -15.81M | -12.89M | -10.63M | -5.96M | -23K |
Net Income | -22.07M | -20.16M | -19M | -19.37M | -21.1M | -22.38M | -22.21M | -22.12M | -22.11M | -19.97M | -18.91M | -14.64M | -13.43M | -15.81M | -12.89M | -10.63M | -5.96M | -23K |
Selling & General & Admin | 8.36M | 7.08M | 6.93M | 7.58M | 7.71M | 7.52M | 7.52M | 7.3M | 7.04M | 6.6M | 6.01M | 4.75M | 3.84M | 4.47M | 3.35M | 2.23M | 1.72M | 23K |
Research & Development | 14.61M | 13.94M | 12.92M | 12.69M | 14.35M | 15.67M | 15.38M | 15.51M | 15.55M | 13.79M | 13.23M | 9.97M | 9.61M | 11.35M | 9.54M | 8.4M | 4.25M | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 22.97M | 21.02M | 19.85M | 20.26M | 22.06M | 23.19M | 22.9M | 22.81M | 22.59M | 20.39M | 19.23M | 14.72M | 13.45M | 15.82M | 12.89M | 10.63M | 5.96M | 23K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 22.97M | 21.02M | 19.85M | 20.26M | 22.06M | 23.19M | 22.9M | 22.81M | 22.59M | 20.39M | 19.23M | 14.72M | 13.45M | 15.82M | 12.89M | 10.63M | 5.96M | 23K |
Income Tax Expense | n/a | n/a | n/a | 1K | 1K | 1K | -51K | -216K | -216K | -224K | -176K | -16K | -16K | -8K | -4K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 21.37M | 19.94M | 17.11M | 17.23M | 16.9M | 16.56M | 17.42M | 16.1M | 15.18M | 14.72M | 14.64M | 14.05M | 12.72M | 12.72M | 12.72M | 11.82M | 12.72M | 12.72M |
Shares Outstanding (Diluted) | 21.37M | 19.94M | 17.11M | 17.23M | 16.9M | 16.56M | 17.42M | 16.1M | 15.18M | 14.72M | 14.64M | 14.05M | 12.72M | 12.72M | 12.72M | 11.82M | 12.72M | 12.72M |
EPS (Basic) | -1.18 | -1.14 | -1.12 | -1.13 | -1.26 | -1.38 | -1.4 | -1.47 | -1.52 | -1.42 | -1.38 | -1.11 | -1.08 | -1.27 | -1.04 | -0.86 | -0.47 | -0.00 |
EPS (Diluted) | -1.18 | -1.14 | -1.12 | -1.13 | -1.26 | -1.38 | -1.4 | -1.47 | -1.52 | -1.42 | -1.47 | -1.2 | -1.17 | -1.36 | -1.04 | -0.86 | -0.47 | -0.00 |
EBITDA | -22.71M | -21.02M | -19.85M | -20.26M | -22.06M | -23.19M | -18.8M | -18.71M | -18.49M | -16.29M | -19.23M | -14.72M | -13.45M | -15.82M | -12.89M | -10.63M | -5.96M | -23K |
EBIT | -22.71M | -21.02M | -19.85M | -20.26M | -22.06M | -23.19M | -22.9M | -22.81M | -22.59M | -20.39M | -19.23M | -14.72M | -13.45M | -15.82M | -12.89M | -10.63M | -5.96M | -23K |
Depreciation & Amortization | n/a | n/a | 43.28K | -956.72K | -996.31K | -874.23K | 3.18M | 2.98M | 3.02M | 2.99M | -1.12M | -7.02M | -2.35M | 3.5M | 3.53M | 10.63M | 5.96M | 23K |